안지오텐신전환효소(ACE) 억제제 시장 : 의약품별, 적응증별, 투여 경로별, 유통 채널별, 지역별
Angiotensin Converting Enzymes Inhibitors Market, By Drugs, By Indication, By Route of Administration, By Distribution Channel, and By Region
상품코드
:
1402607
리서치사
:
Coherent Market Insights
발행일
:
2023년 12월
페이지 정보
:
영문
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
안지오텐신전환효소(ACE) 억제제 세계 시장 규모는 2023년 80억 7,050만 달러에서 2030년 118억 3,170만 달러에 달할 것으로 예상되며, 2023-2030년 예측 기간 동안 5.6%의 CAGR을 기록할 것으로 예상됩니다.
| 보고 대상 범위 |
보고서 상세 |
| 기준 연도 |
2022년 |
2023년 시장 규모 |
80억 7,050만 달러 |
| 실적 데이터 |
2018-2021년 |
예측 기간 |
2023-2030년 |
| 예측 기간의 CAGR |
5.60% |
2030년 시장 규모 예측 |
118억 3,170만 달러 |
그림 1. 안지오텐신전환효소(ACE) 억제제 세계 시장 점유율(%), 지역별, 2023년
안지오텐신전환효소(ACE) 억제제는 주로 고혈압과 심부전 치료에 사용되는 약물의 일종입니다. 안지오텐신 II라는 호르몬의 작용을 억제해 효과를 발휘합니다. 안지오텐신Ⅱ는 혈관을 수축시키고 알도스테론이라는 또 다른 호르몬의 분비를 촉진해 체내 수분과 염분을 저장하게 되는데, ACE 억제제는 안지오텐신Ⅱ의 생성을 억제해 혈관을 이완 및 확장시켜 체내 수분 보유량을 감소시켜 혈압을 낮추는 역할을 합니다. 일반적으로 처방되는 ACE 억제제에는 리시노프릴, 에날라프릴, 라미프릴 등이 있습니다. 부작용으로는 헛기침, 어지럼증, 신장 장애 등이 있으며, ACE 억제제를 복용하는 사람은 정기적인 검진을 통해 신장 기능과 칼륨 수치를 모니터링하는 것이 중요합니다. ACE 억제제는 안지오텐신 II의 작용을 완화하여 혈관의 이완과 확장을 돕고 체액 저류를 조절하여 혈압을 낮추는 데 매우 중요한 역할을 합니다.
시장 역학
세계 안지오텐신전환효소(ACE) 억제제 시장의 성장은 전 세계적으로 고혈압과 심장병의 높은 유병률에 의해 주도되고 있습니다. 우리 몸은 4종류의 안지오텐신(an-gee-oh-ten-sin, 로마 숫자로 표기)이라는 호르몬을 생산합니다. 안지오텐신 i은 ACE에 의해 안지오텐신 II로 전환되어 다양한 신체적 영향을 미치는데, ACE 억제제는 특히 심혈관계 질환과 고혈압에 자주 권장됩니다. ACE 억제제는 2019년에 1,290만 명 이상의 메디케어 파트 D 가입자(전체 파트 D 가입자의 약 27%)에게 투여되었으며, ACE 억제제가 부작용을 유발할 수 있는 것은 사실입니다. 대부분 경미하지만, 일부 부작용이 발생하기도 합니다. 대부분 경미하지만, 소수는 응급처치가 필요한 위험한 질환도 있습니다.
본 조사의 주요 특징
- 이 보고서는 세계 안지오텐신전환효소(ACE) 억제제 시장을 상세히 분석하고 2022년을 기준 연도로 하여 예측 기간(2023-2030년)의 시장 규모와 연평균 성장률(CAGR)을 제시합니다.
- 또한 다양한 부문의 잠재적 수익 기회를 파악하고 이 시장에 대한 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택한 경쟁 전략 등에 대한 중요한 고려 사항도 제공합니다.
- 세계 안지오텐신전환효소(ACE) 억제제 시장의 주요 기업을 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 성과, 전략 등의 매개 변수를 기반으로 프로파일링합니다.
- 이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형화, 시장 확대 및 마케팅 전술에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
- 세계 안지오텐신전환효소(ACE) 억제제 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 이 산업의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자는 세계 안지오텐신전환효소(ACE) 억제제 시장을 분석할 때 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.
목차
제1장 조사 목적과 가정
제2장 시장 전망
- 보고서 설명
- 주요 요약
- Coherent Opportunity Map(COM)
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 고혈압 유병률 상승
- 성장하는 연구개발 활동
- 심혈관 건강에 대한 의식 향상
- 특허 만료
- 부작용과 안전성에 대한 우려
- 부작용과 안전성에 대한 우려
- 심혈관 건강에 대한 의식 향상
- 맞춤형 의료
- 병용요법
- 영향 분석
- 주요 하이라이트
- 규제 시나리오
- 제품 발매/승인
- PEST 분석
- Porters 분석
- 인수합병 시나리오
제4장 세계의 안지오텐신전환효소(ACE) 억제제 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향
- 신종 코로나바이러스 감염증(COVID-19) 역학
- 공급측과 수요측 분석
- 경제적 영향
제5장 세계의 안지오텐신전환효소(ACE) 억제제 시장, 의약품별, 2018-2030년
- Benazepril
- Perindopril
- Trandfolapril
- Captopril
- Enalapril
- Lisinopril
- 기타(Ramipril 등)
제6장 세계의 안지오텐신전환효소(ACE) 억제제 시장, 적응증별, 2018-2030년
- 고혈압
- 관상동맥질환
- 심부전
- 만성신장병
- 경피증
- 기타(편두통 등)
제7장 세계의 안지오텐신전환효소(ACE) 억제제 시장, 투여 경로별, 2018-2030년
제8장 세계의 안지오텐신전환효소(ACE) 억제제 시장, 유통 채널별, 2018-2030년
제9장 세계의 안지오텐신전환효소(ACE) 억제제 시장, 지역별, 2018-2030년
- 북미
- 미국
- 캐나다
- 유럽
- 영국
- 독일
- 이탈리아
- 프랑스
- 스페인
- 러시아
- 기타 유럽
- 아시아태평양
- 중국
- 인도
- 일본
- ASEAN
- 호주
- 한국
- 기타 아시아태평양
- 라틴아메리카
- 브라질
- 멕시코
- 아르헨티나
- 기타 라틴아메리카
- 중동 및 아프리카
- GCC
- 이스라엘
- 북아프리카
- 중앙아프리카
- 기타 중동 및 아프리카
제10장 경쟁 상황
- Novartis AG
- Pfizer Inc.
- Merck & Co.
- AstraZeneca
- Sanofi
- Boehringer Ingelheim
- GlaxoSmithKline
- Lupin Limited
- Torrent Pharmaceuticals Ltd.
- Reddy's Laboratories Ltd.
- Mylan
제11장 섹션
ksm
영문 목차
The global angiotensin converting enzymes (ACE) inhibitors market size is projected to reach US$ 11,831.7 million by 2030, from US$ 8,070.5 million in 2023, at a CAGR of 5.6% during the forecast period 2023-2030.
| Report Coverage |
Report Details |
| Base Year: |
2022 |
Market Size in 2023: |
US$ 8,070.5 Mn |
| Historical Data for: |
2018 to 2021 |
Forecast Period: |
2023 - 2030 |
| Forecast Period 2023 to 2030 CAGR: |
5.60% |
2030 Value Projection: |
US$ 11,831.7 Mn |
Figure 1. Global Angiotensin Converting Enzymes (ACE) Inhibitors Market Share (%), By Region, 2023
Angiotensin converting enzymes (ACE) inhibitors are a type of medication used primarily in the treatment of high blood pressure and heart failure. They work by blocking the action of a hormone called angiotensin II. Angiotensin II causes blood vessels to constrict and promotes the release of another hormone called aldosterone, which leads to water and salt retention in the body. By inhibiting the production of angiotensin II, ACE inhibitors help to relax and widen the blood vessels, reduce the amount of water retained by the body, and therefore lower blood pressure. Commonly prescribed ACE inhibitors include lisinopril, enalapril, and ramipril. Side effects can include dry cough, dizziness, and kidney problems. It is important for individuals taking ACE inhibitors to have regular check-ups to monitor their kidney function and potassium levels. ACE inhibitors play a pivotal role in mitigating the effects of angiotensin II, aiding in the relaxation and widening of blood vessels while regulating fluid retention, thus contributing significantly to blood pressure reduction.
Market Dynamics
The global angiotensin converting enzymes (ACE) inhibitors market's growth is driven by the high prevalence of hypertension and heart disease globally. The body produces four distinct forms of the hormone angiotensin (an-gee-oh-ten-sin; the types' names are Roman numerals). Angiotensin I is converted to angiotensin II by ACE, which has a variety of bodily consequences. ACE inhibitors are often recommended, particularly for cardiovascular diseases and high blood pressure. An ACE inhibitor was given to over 12.9 million Medicare Part D participants in 2019 (or roughly 27% of all beneficiaries with Part D coverage). It is true that ACE inhibitors can cause negative effects. Most of them are mild, but a few are dangerous and require emergency medical attention.
Key features of the study:
- This report provides in-depth analysis of the global angiotensin converting enzymes (ACE) inhibitors market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global angiotensin converting enzymes (ACE) inhibitors market based on the following parameters-company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Novartis AG, Pfizer Inc., Merck & Co., AstraZeneca, Sanofi, Boehringer Ingelheim, GlaxoSmithKline, Lupin Limited, Torrent Pharmaceuticals Ltd., Dr. Reddy's Laboratories Ltd., Mylan and Other Prominent Players
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global angiotensin converting enzymes (ACE) inhibitors market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global angiotensin converting enzymes (ACE) inhibitors market
Detailed Segmentation:
- Global Angiotensin Converting Enzymes (ACE) Inhibitors Market, By Drugs:
- Benazepril
- Perindopril
- Trandfolapril
- Captopril
- Enalapril
- Lisinopril
- Others (Ramipril, etc.)
- Global Angiotensin Converting Enzymes (ACE) Inhibitors Market, By Indication:
- Hypertension
- Coronary Artery Disease
- Heart Failure
- Chronic Kidney Disease
- Scleroderma
- Others (Migraine, etc.)
- Global Angiotensin Converting Enzymes (ACE) Inhibitors Market, By Route of Administration:
- Global Angiotensin Converting Enzymes (ACE) Inhibitors Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Global Angiotensin Converting Enzymes (ACE) Inhibitors Market, By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East &Africa
- Company Profiles:
- Novartis AG
- Pfizer Inc.
- Merck & Co.
- AstraZeneca
- Sanofi
- Boehringer Ingelheim
- GlaxoSmithKline
- Lupin Limited
- Torrent Pharmaceuticals Ltd.
- Reddy's Laboratories Ltd.
- Mylan
- Other Prominent Players
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Angiotensin Converting Enzymes (ACE) Inhibitors, By Drugs
- Market Angiotensin Converting Enzymes (ACE) Inhibitors, By Indication
- Market Angiotensin Converting Enzymes (ACE) Inhibitors, By Route of Administration
- Market Angiotensin Converting Enzymes (ACE) Inhibitors, By Distribution Channel
- Market Angiotensin Converting Enzymes (ACE) Inhibitors, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Rising prevalence of hypertension
- Growing Research and Development Activities
- Increasing Awareness of Cardiovascular Health
- Patent Expirations
- Side Effects and Safety Concerns
- Side Effects and Safety Concerns
- Increasing Awareness of Cardiovascular Health
- Personalized medicine
- Combination therapies
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launch/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Angiotensin Converting Enzymes (ACE) Inhibitors Market - Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
5. Global Angiotensin Converting Enzymes (ACE) Inhibitors Market, By Drugs, 2018-2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019-2030
- Segment Trends
- Benazepril
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Perindopril
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Trandfolapril
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Captopril
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Enalapril
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Lisinopril
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Others (Ramipril, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
6. Global Angiotensin Converting Enzymes (ACE) Inhibitors Market, By Indication, 2018-2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019-2030
- Segment Trends
- Hypertension
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn )
- Coronary Artery Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn )
- Heart Failure
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn )
- Chronic Kidney Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn )
- Scleroderma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
- Others (Migraine, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
7. Global Angiotensin Converting Enzymes (ACE) Inhibitors Market, By Route of Administration, 2018-2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019-2030
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Injectable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
8. Global Angiotensin Converting Enzymes (ACE) Inhibitors Market, By Distribution Channel, 2018-2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019-2030
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
9. Global Angiotensin Converting Enzymes (ACE) Inhibitors Market, By Region, 2018-2030, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Region, 2019 -2030
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Mn)
- GCC
- Israel
- North Africa
- Central Africa
- Rest of Middle East & Africa
10. Competitive Landscape
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pfizer Inc.
- Merck & Co.
- AstraZeneca
- Sanofi
- Boehringer Ingelheim
- GlaxoSmithKline
- Lupin Limited
- Torrent Pharmaceuticals Ltd.
- Reddy's Laboratories Ltd.
- Mylan
- Analyst Views
11. Section
- Research Methodology
- About us
관련자료
